Cibus Inc (CBUS) Noticias

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape

Cibus and Biographica to collaborate on identifying gene editing targets for Cibus’ disease resistance trait...

Form 8-K - Current report

Form 144 - Report of proposed sale of securities

Cibus to Participate in the 13th Annual Roth Technology Conference

SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading...

Cibus Achieves Additional Milestone for Next Generation Gene Edits for Sclerotinia Resistance in Canola

Cibus has successfully made the edits in Canola associated with the Company’s 4th mode of action for its White...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2024

Announced a strategic realignment to advance commercial opportunities, focusing resources on advancement of...